Lipoprotein (a) in patients with spontaneous venous thromboembolism

Thrombosis Research
Rainer VormittagIngrid Pabinger

Abstract

Elevated lipoprotein (a) (Lp (a)) has been established as a risk factor of coronary heart disease and stroke. Findings concerning the risk of venous thromboembolism (VTE) in adults are contradictory. The aim of our study was to investigate, whether elevated Lp (a) levels are an independent risk factor of spontaneous symptomatic venous thromboembolism (VTE). Our study was further designed to detect differences in risk profiles between thrombosis patients with and without symptomatic PE. We investigated Lp (a) in 128 patients with spontaneous symptomatic deep vein thrombosis (DVT, group 1), 105 with spontaneous symptomatic pulmonary embolism with or without DVT (PE, group 2) and 122 healthy controls. Lp (a) was measured with an immunoturbidimetric assay (Tina-quant(R), Roche, Grenzach-Wyhlen, Germany) on a Hitachi-Modular system. Lp (a) levels (mg/L) were not significantly different among groups, median levels (25th-75th percentiles) were 170 (51-386) in group 1, 140 (<20-427) in group 2 and 126 (54-331) in controls, respectively. As continuous variable, odds ratios for VTE for a 100 mg/L increase of Lp (a) were 1.1 [95% confidence interval 0.98-1.2] for group 1 versus controls and 1.1 [0.95-1.2] for group 2 versus controls. The ...Continue Reading

References

Dec 1, 1991·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·J M Edelberg, S V Pizzo
Apr 26, 1995·JAMA : the Journal of the American Medical Association·P M RidkerC H Hennekens
Jul 24, 1998·Clinical Chemistry and Laboratory Medicine : CCLM·R GarnotelP Gillery
Oct 18, 2000·Twin Research : the Official Journal of the International Society for Twin Studies·D I BoomsmaH M Princen
Jan 30, 2002·Frontiers in Bioscience : a Journal and Virtual Library·Jiyun Kim, Katherine A Hajjar
Apr 12, 2002·Diabetic Medicine : a Journal of the British Diabetic Association·T H MacaE Minar
Oct 31, 2002·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Darren S ParsonsEdwina A Brown
Feb 1, 2003·Clinica Chimica Acta; International Journal of Clinical Chemistry·Davide NotoMaurizio Averna
Mar 11, 2003·European Journal of Clinical Nutrition·Z W XiongY L Lim
Dec 6, 2003·The American Journal of Medicine·Rossella MarcucciDomenico Prisco

❮ Previous
Next ❯

Citations

Jun 8, 2011·Journal of Environmental and Public Health·Diane L ElliotEsther L Moe
Nov 11, 2010·Clinical Chemistry and Laboratory Medicine : CCLM·Alenka Trampus-Bakija
Nov 18, 2008·European Journal of Internal Medicine·Massimo Franchini, Pier Mannuccio Mannucci
Nov 10, 2012·Journal of Thrombosis and Haemostasis : JTH·J S DanikR J Glynn
Nov 9, 2016·Aging Clinical and Experimental Research·Giulia MalaguarneraSaverio Latteri
Nov 3, 2016·Journal of Lipid Research·Børge G Nordestgaard, Anne Langsted
Dec 28, 2007·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Jana HirmerovaTreska Vladislav
Dec 5, 2018·Journal of Thrombosis and Thrombolysis·Anna Aleksandra SkuzaAnetta Undas
May 30, 2021·Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association·Mohamad AbdalkaderThanh N Nguyen
Oct 15, 2021·Arteriosclerosis, Thrombosis, and Vascular Biology·Gissette Reyes-SofferUNKNOWN American Heart Association Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular Radiology
Oct 30, 2021·Journal of Internal Medicine·Byambaa Enkhmaa, Lars Berglund

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.